A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
In addition from Q1 2019 Therapy Watch will now be tracking prescription topical treatments in both a secondary care and primary care setting providing broad visibility of the psoriasis market landscape.
Therapy Watch PsO is part of our wider auto-immune portfolio which covers rheumatology, dermatology and gastroenterology. Therapy Watch is a syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed, quality and up-to-date access to the very latest market data, Therapy Watch offers a clear advantage by putting you in closer contact with your market than ever before.
Watch our video in which Director, Helen Parfitt explains the benefits of Therapy Watch »
Research Partnership also offers a range of syndicated patient research reports called “Living With”. A Living with psoriasis report is available to purchase, as are our Rheumatoid Arthritis and Psoriatic Arthritis reports thereby offering a complete auto-immune portfolio.
All the latest news from Research Partnership